Duff & Phelps Investment Management CO Abbott Laboratories Transaction History

Duff & Phelps Investment Management CO

$8.58 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.62 Million - $1.8 Million	-16,039 Reduced 80.14%	3,975 $413,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $80,387 - $88,784	734 Added 3.81%	20,014 $2.27 Million
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $9,019 - $11,040	100 Added 0.52%	19,280 $2.12 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $15,666 - $18,797	164 Added 0.86%	19,180 $1.86 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $25,517 - $30,842	250 Added 1.33%	19,016 $2.07 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $2,280 - $2,780	20 Added 0.11%	18,766 $2.22 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $15,134 - $18,531	131 Added 0.7%	18,746 $2.64 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $47,830 - $52,914	-410 Reduced 2.16%	18,615 $2.2 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $181,429 - $213,568	-1,715 Reduced 8.27%	19,025 $2.21 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $29,386 - $34,622	-270 Reduced 1.29%	20,740 $2.49 Million
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $21,000 - $22,884	200 Added 0.96%	21,010 $2.3 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $50,536 - $64,680	660 Added 3.28%	20,810 $1.9 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $27,640 - $40,418	440 Added 2.23%	20,150 $1.59 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $31,404 - $34,960	400 Added 2.07%	19,710 $1.71 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $14,576 - $17,000	200 Added 1.05%	19,310 $1.62 Million
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $19,866 - $24,018	300 Added 1.59%	19,110 $1.53 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $26,224 - $29,708	400 Added 2.17%	18,810 $1.36 Million
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $3,040 - $3,668	-50 Reduced 0.27%	18,410 $1.35 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $17,271 - $19,062	-300 Reduced 1.6%	18,460 $1.13 Million
Q1 2018 May 01, 2018	SELL	$56.27 - $63.62 $24,196 - $27,356	-430 Reduced 2.24%	18,760 $1.12 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $16,640 - $17,815	-310 Reduced 1.59%	19,190 $1.1 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $937,170 - $1.05 Million	19,500	19,500 $1.04 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Duff & Phelps Investment Management CO with notifications on news.

Account